- $2.33bn
- $6.44bn
- $2.56bn
- 56
- 92
- 43
- 70
Annual income statement for CLARIVATE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,254 | 1,877 | 2,660 | 2,629 | 2,557 |
| Cost of Revenue | |||||
| Gross Profit | 825 | 1,251 | 1,706 | 1,722 | 1,688 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,456 | 1,883 | 6,379 | 3,364 | 2,832 |
| Operating Profit | -202 | -5.66 | -3,719 | -735 | -276 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -314 | -258 | -3,989 | -1,013 | -554 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -312 | -270 | -3,960 | -982 | -637 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -312 | -270 | -3,960 | -911 | -637 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -312 | -312 | -4,036 | -987 | -668 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.544 | -0.313 | -1.88 | -0.627 | -0.472 |
| Dividends per Share |